Polyrizon signs all five U.S. sites for NASARIX allergy trial
Go back to Polyrizon signs all five U.S. sites for NASARIX allergy trial| (NASDAQ: PLRZ) | Delayed: 10.99 -0.04 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.03 | 52 Week High | $ | |||
| Open | $11.01 | 52 Week Low | $ | |||
| Day High | $11.07 | P/E | N/A | |||
| Day Low | $10.36 | EPS | $ | |||
| Volume | 32,056 | |||||

